These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21320038)

  • 1. Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
    Minowa K; Amano H; Nakano S; Ando S; Watanabe T; Nakiri Y; Amano E; Tokano Y; Morimoto S; Takasaki Y
    Autoimmunity; 2011 Aug; 44(5):357-62. PubMed ID: 21320038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus.
    Chu VT; Enghard P; Schürer S; Steinhauser G; Rudolph B; Riemekasten G; Berek C
    Arthritis Rheum; 2009 Jul; 60(7):2083-93. PubMed ID: 19565488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M; Kim D; Oh M; Jeong H; Choi I
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
    Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
    Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY
    J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.
    Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF
    Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
    Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
    Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
    Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
    Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients.
    Hong SD; Reiff A; Yang HT; Migone TS; Ward CD; Marzan K; Shaham B; Phei WC; Garza J; Bernstein B; Stohl W
    Arthritis Rheum; 2009 Nov; 60(11):3400-9. PubMed ID: 19877053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
    Eilertsen GØ; Nossent JC
    Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.